PTEN and neoplasm: In addition, they evaluated the antitumor effect of mPTEN@NPs combined with anti-PD-1 immunotherapy in tumor models with PTEN deletion or mutation, suggesting that this combination therapy strategy had significant therapeutic efficacy and immune memory.